Remove tag trial-recruitment
article thumbnail

CHMP backs J&J’s myeloma bispecific Tecvayli, ahead of US decision

pharmaphorum

It showed an overall response rate with Tecvayli of 63%, including 39% complete responses which is a remarkable result given that the patient recruited into the trial were very ill and heavily pre-treated. Tecvayli previously scored a priority medicines (PRiME) designation from the EMA and a breakthrough-therapy tag from the FDA.

FDA 52
article thumbnail

A history of Pfizer

pharmaphorum

Pfizer’s international expansion put great trust in their local staff compared to other organisations, recruiting nationals and giving them a great deal of autonomy. Likewise, tanezumab, an anti-osteoarthritic, failed in trials. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

Disappointing late-stage trials of CureVac’s jab meant there was no competitive advantage, while Sanofi said the dominance of current vaccines made penetration in the market difficult. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Pfizer is understood to have charged $19.50 per dose in the US and €19.50

Vaccines 137
article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). Informed consent is crucial to recruiting the patient to the study.

article thumbnail

8 Biggest Trends in Healthcare Marketing in 2023

Viseven

In addition, AI-driven software attracts pharma companies that study its potential in new drug discovery, patient diagnostics automation, and clinical trials which is great for recruitment campaigns.

article thumbnail

TG Therapeutics challenges Roche with FDA filing for CLL drug

pharmaphorum

Aside from Gazyvaro, CLL can be treated with older chemotherapy agents, or Roche/AbbVie’s Venclexta (venetoclax) in some instances, and the fast track tag showed the FDA considered the combination to be a promising new contender on the market. TG said it expects the data submission to be complete in the first half of 2021.

FDA 52
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. One highly anticipated study is Mounjaro’s SURMOUNT-MMO Phase III clinical trial. Novo Nordisk is another company leading the charge in this field. compared to a 5.1%

Insurance 105